Literature DB >> 18608135

Short-term electrophysiological effects of losartan, bisoprolol, amlodipine, and hydrochlorothiazide in hypertensive men.

Kimmo Porthan1, Matti Viitasalo, Timo P Hiltunen, Heikki Vaananen, Juhani Dabek, Timo Suonsyrja, Tuula Hannila-Handelberg, Juha Virolainen, Markku S Nieminen, Lauri Toivonen, Kimmo Kontula, Lasse Oikarinen.   

Abstract

BACKGROUND AND AIM: Hypertension-induced left ventricular structural remodelling associates with repolarization abnormalities. We investigated if antihypertensive drugs can modulate ventricular repolarization.
METHODS: A total of 183 hypertensive men received for 4 weeks drugs (losartan 50 mg, bisoprolol 5 mg, amlodipine 5 mg, hydrochlorothiazide (HCTZ) 25 mg) in a randomized order, separated by 4-week placebo periods. Electrocardiograms (ECG) were recorded at the end of placebo and drug periods. Measurements of repolarization duration (QT intervals), repolarization heterogeneity (T-wave peak to T-wave end (TPE) intervals), and T-wave morphology (T-wave principal component analysis (PCA) ratio, T-wave morphology dispersion (TMD), and total cosine R-to-T (TCRT)) during each drug were compared to placebo measurements.
RESULTS: Losartan and bisoprolol shortened maximum and mean rate-adjusted QT intervals as well as mean TPE interval, decreased TMD, and increased TCRT. Losartan also shortened precordial maximum TPE interval and decreased PCA ratio. Amlodipine had no repolarization effects, whereas HCTZ prolonged precordial maximum TPE interval and mean TPE interval.
CONCLUSION: Losartan and bisoprolol have beneficial short-term ECG repolarization effects. Amlodipine seems to have no repolarization effects. HCTZ seems to prolong the ECG TPE interval, potentially reflecting increased repolarization heterogeneity. These findings show that antihypertensive drugs may relatively rapidly and treatment-specifically modulate ECG markers of ventricular repolarization.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18608135     DOI: 10.1080/07853890802195211

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  5 in total

Review 1.  Modulation of the QT interval duration in hypertension with antihypertensive treatment.

Authors:  Jan Klimas; Peter Kruzliak; Simon W Rabkin
Journal:  Hypertens Res       Date:  2015-03-19       Impact factor: 3.872

2.  QTc interval in young Gujarati hypertensives: Effect of disease, antihypertensive monotherapy, and coexisting risk factors.

Authors:  Jayesh Dalpatbhai Solanki; Bhakti P Gadhavi; Amit H Makwana; Hemant B Mehta; Chinmay J Shah; Pradnya A Gokhale
Journal:  J Pharmacol Pharmacother       Date:  2016 Oct-Dec

3.  Subclinical ventricular repolarization abnormality in uncontrolled compared with controlled treated hypertension.

Authors:  Marwan S M Al-Nimer; Ismail I Hussein
Journal:  Indian Heart J       Date:  2016-08-04

4.  Severity and multiplicity of microvascular complications are associated with QT interval prolongation in patients with type 2 diabetes.

Authors:  Shunsuke Kobayashi; Mototsugu Nagao; Akira Asai; Izumi Fukuda; Shinichi Oikawa; Hitoshi Sugihara
Journal:  J Diabetes Investig       Date:  2017-12-13       Impact factor: 4.232

5.  Effect of four classes of antihypertensive drugs on cardiac repolarization heterogeneity: A double-blind rotational study.

Authors:  Heini Sánez Tähtisalo; Timo P Hiltunen; Tuomas Kenttä; Juhani Junttila; Lasse Oikarinen; Juha Virolainen; Kimmo K Kontula; Kimmo Porthan
Journal:  PLoS One       Date:  2020-03-24       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.